leukemia/fatigue

OBJECTIVE To describe fatigue severity, fatigue interference, and associated factors in hematologic malignancies. METHODS Patients being treated for leukemia and non-Hodgkin's lymphoma (n = 228) completed the Brief Fatigue Inventory to rate fatigue severity and functional interference caused by

Background: Cancer-related Fatigue (CRF) is one of the most common complications of acute myeloid leukemia(AML) and its related therapies. It can influence all physical and psychological aspects of the patient’s life. Also, itis believed that exercise can improve CRF in patients with cancer.

Cancer-related fatigue (CRF) is a major problem in patients with acute myeloid leukemia (AML) and may be mediated by circulating cytokines. We examined this relationship in 74 adult AML patients before and after the first cycle of induction chemotherapy. Plasma levels of 13 cytokines were measured

Treatment-related fatigue significantly limits quality of life among chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitors (TKIs), yet no interventions to reduce this symptom have been studied. We examined preliminary feasibility and efficacy of cognitive behavioral therapy

OBJECTIVE To determine the feasibility of collecting symptom data at home from school-age children with acute lymphoblastic leukemia (ALL) and from their fathers and mothers and to obtain initial descriptions of pain, sleep disturbance, and fatigue experienced by the family members at

Fatigue is a common side effect of tyrosine kinase inhibitor (TKI) therapy in chronic myeloid leukemia (CML) patients. However, the prevalence of TKI-induced fatigue remains uncertain and little is known about predictors of fatigue and its relationship with physical activity. In this study, 220 CML

Health-related quality of life (HRQoL) is an important endpoint, especially in clinical trials for malignancies with a long course of disease, such as chronic lymphocytic leukemia (CLL). Patient-reported outcomes were examined in the randomized, double-blind, placebo-controlled HELIOS study to

The present work is a study with the objective of learning the conceptions of the patient bearer of acute myeloid leukemia (AML) concerning to fatigue symptoms and their repercussions in his/her daily life as well as the actions performed in order to minimize the fatigue. It is a descriptive and

BACKGROUND The goal of treating chronic diseases, including hematologic malignancies, is to increase patients' life span and to improve their capabilities as much as possible; so that patients could maintain an appropriate level of quality of life (QoL) and continue their lives. Most studies

Previous studies have examined physical exercise as a way to lower the fatigue of children with cancer in a hospital setting, but there have been no such studies in a home setting. Therefore, this study identifies the relationship between physical activity and fatigue in children undergoing

Acute myeloid leukemia (AML) is associated with poor survival. While clinical prognostic factors of survival have been identified, the contribution of patient-reported symptoms has only received marginal attention. Fatigue is one of the most commonly reported symptoms of AML. There is some evidence

The xenotropic murine leukemia virus-related virus (XMRV) has been recently linked to chronic fatigue syndrome in a US cohort in whom the virus was demonstrated in 67% patients vs 3.7% healthy controls. Albeit this finding was not substantiated by subsequent reports and eventually

The purpose of this randomized, controlled clinical trial was to preliminarily examine the effects of a three-week walking exercise program (WEP) on fatigue-related experiences of acute myelogenous leukemia (AML) patients receiving chemotherapy. Eligible AML patients were randomly assigned to either

BACKGROUND Fatigue in cancer survivors is a serious problem in pediatric oncology, but reports on this issue are limited, especially in Asian countries. METHODS Sixty-three patients with acute lymphoblastic leukemia and 18 patients with acute myeloid leukemia who attended a follow-up outpatient